Literature DB >> 19653102

Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part II: biological evaluation.

Hussein O Ammar1, Mahmoud Ghorab, Soheir A El-Nahhas, Rabab Kamel.   

Abstract

This study is an extrapolation of our previous one (part I) concerned with the formulation and physicochemical evaluation of a novel, simple, monolayer, easy-to-use, cost-effective, and aesthetically acceptable bioadhesive transdermal patch for tramadol hydrochloride. The current work is focused on bioadhesion, skin tolerability, and pharmacodynamic evaluation. Using naked rat skin, chitosan-Eudragit NE30D (1:1) film attained best bioadhesive properties. During in vivo studies, it also showed a significantly extended analgesic effect compared to both oral formula and chitosan single polymeric film using the hot plate test method. All the polymeric films were skin tolerable for the intended period of application according to the Draize test. The success of our approach can proudly, positively contribute into the world of pain management and arguably push transdermal delivery to realize its great promise.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653102      PMCID: PMC2802134          DOI: 10.1208/s12249-009-9294-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  21 in total

Review 1.  Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.

Authors:  Anna M Wokovich; Suneela Prodduturi; William H Doub; Ajaz S Hussain; Lucinda F Buhse
Journal:  Eur J Pharm Biopharm       Date:  2006-04-15       Impact factor: 5.571

2.  Development of opioid formulations with limited diversion and abuse potential.

Authors:  Paul J Fudala; Rolley E Johnson
Journal:  Drug Alcohol Depend       Date:  2006-03-24       Impact factor: 4.492

3.  An investigation of bioadhesion for periodontal and oral mucosal drug delivery.

Authors:  I G Needleman; F C Smales; G P Martin
Journal:  J Clin Periodontol       Date:  1997-06       Impact factor: 8.728

4.  Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain.

Authors:  H Malonne; M Coffiner; D Fontaine; B Sonet; A Sereno; A Peretz; F Vanderbist
Journal:  J Clin Pharm Ther       Date:  2005-04       Impact factor: 2.512

5.  Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery.

Authors:  S Cafaggi; R Leardi; B Parodi; G Caviglioli; E Russo; G Bignardi
Journal:  J Control Release       Date:  2005-01-20       Impact factor: 9.776

Review 6.  A risk-benefit assessment of tramadol in the management of pain.

Authors:  L Radbruch; S Grond; K A Lehmann
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

7.  Characterization of cellulosic hot-melt extruded films containing lidocaine.

Authors:  Michael A Repka; Kavitha Gutta; Suneela Prodduturi; Manish Munjal; Steven P Stodghill
Journal:  Eur J Pharm Biopharm       Date:  2005-01       Impact factor: 5.571

8.  Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.

Authors:  A Akhgari; F Farahmand; H Afrasiabi Garekani; F Sadeghi; T F Vandamme
Journal:  Eur J Pharm Sci       Date:  2006-03-28       Impact factor: 4.384

Review 9.  Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.

Authors:  Robert L Barkin
Journal:  Am J Ther       Date:  2008 Mar-Apr       Impact factor: 2.688

10.  Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.

Authors:  Sandip B Tiwari; T Krishna Murthy; M Raveendra Pai; Pavak R Mehta; Pasula B Chowdary
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

View more
  4 in total

1.  Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCl for pediatric use: in-vitro/in-vivo evaluation and histopathological examination.

Authors:  Rabab Kamel; Haidy Abbas; Mona El-Naa
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  Glycerosomal thermosensitive in situ gel of duloxetine HCl as a novel nanoplatform for rectal delivery: in vitro optimization and in vivo appraisal.

Authors:  Heba F Salem; Adel A Ali; Yasmine K Rabea; Fatma I Abo El-Ela; Rasha A Khallaf
Journal:  Drug Deliv Transl Res       Date:  2022-05-27       Impact factor: 4.617

3.  Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance.

Authors:  Fatma A Moawad; Adel A Ali; Heba F Salem
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Mitigation of Rheumatic Arthritis in a Rat Model via Transdermal Delivery of Dapoxetine HCl Amalgamated as a Nanoplatform: In vitro and in vivo Assessment.

Authors:  Heba Farouk Salem; Mohamed Mahmoud Nafady; Rasha Mostafa Kharshoum; Omnia Ahmed Abd El-Ghafar; Hanan Osman Farouk
Journal:  Int J Nanomedicine       Date:  2020-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.